What is the management for a patient with hematemesis presenting with coffee ground emesis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Coffee Ground Emesis

Immediately establish two large-bore IV cannulae (18-gauge or larger) in the antecubital fossae and begin rapid fluid resuscitation with normal saline while simultaneously assessing hemodynamic status and preparing for urgent upper endoscopy within 24 hours. 1, 2

Immediate Resuscitation and Stabilization

Vascular Access and Fluid Management

  • Insert two large-bore peripheral IV cannulae (18-gauge or larger) in the antecubital fossae for all patients presenting with coffee ground emesis 3, 1, 2
  • Begin rapid infusion of normal saline, typically 1-2 liters initially, to achieve hemodynamic stability (falling pulse rate, rising blood pressure, adequate urine output) 3, 1
  • If the patient remains in shock after initial 1-2 liters of crystalloid, administer plasma expanders as this indicates at least 20% blood volume loss 3, 1

Hemodynamic Monitoring

  • Continuously monitor pulse and blood pressure using automated monitoring equipment 3, 2
  • Insert a urinary catheter and measure hourly urine output in severe cases (target >30 ml/hour indicates adequate resuscitation) 3, 1
  • Consider central venous pressure monitoring in patients with significant cardiac disease to guide fluid replacement (target CVP 5-10 cm H₂O) 3, 1

Airway Protection

  • Strongly consider endotracheal intubation before endoscopy if the patient has active hematemesis, inability to maintain or protect their airway, or altered mental status 3
  • This is critical to prevent pulmonary aspiration during endoscopy, particularly in severely bleeding patients 3

Risk Stratification

Classify severity based on the following parameters 3, 1:

Severe bleeding indicators:

  • Age >60 years
  • Pulse >100 beats/min
  • Systolic blood pressure <100 mm Hg
  • Hemoglobin <100 g/L (10 g/dL)
  • Presence of significant comorbidities (cardiac disease, liver disease, renal failure)

Laboratory Tests to Order STAT

  • Complete blood count with hemoglobin and hematocrit 2
  • Coagulation profile (PT/INR, PTT) 2
  • Type and cross-match for blood products 2
  • Serum lactate and base deficit to assess severity of shock 2

Blood Transfusion Criteria

Transfuse packed red blood cells when: 3, 2

  • Hemoglobin <70 g/L (7 g/dL) in hemodynamically stable patients
  • Hemoglobin <100 g/L (10 g/dL) in patients with active bleeding and hemodynamic instability
  • Target hemoglobin of 70-100 g/L for most patients, but maintain 100 g/L in actively bleeding patients, elderly, or those at risk for myocardial infarction

Important caveat: Use a restrictive transfusion strategy (target Hgb 7-9 g/dL) as this is associated with decreased mortality and reduced rebleeding rates 3

Pharmacological Management

Proton Pump Inhibitors

  • Administer high-dose intravenous omeprazole: 80 mg IV bolus followed by continuous infusion of 8 mg/hour for 72 hours 3, 2
  • This should be given immediately in the acute setting to decrease the probability of high-risk stigmata at endoscopy 4

Vasoactive Drugs (if variceal bleeding suspected)

  • Start octreotide if there is any suspicion of portal hypertension or liver disease: 50 mcg IV bolus (can repeat in first hour if ongoing bleeding), followed by continuous infusion of 50 mcg/hour for 2-5 days 3
  • Somatostatin analogs inhibit gastric acid secretion, so co-administration of PPI is not required 3

Antibiotic Prophylaxis

  • Administer prophylactic antibiotics if liver disease is suspected: ceftriaxone 1 g IV every 24 hours (maximum 7 days) 3, 2
  • This reduces infections, rebleeding, and mortality in patients with cirrhosis 3

Prokinetic Agents

  • Consider erythromycin 250 mg IV given 30-120 minutes before endoscopy to improve visualization (check QT interval first) 3, 4

Endoscopy Timing and Preparation

  • Perform upper endoscopy within 24 hours of presentation after initial hemodynamic stabilization 3, 1, 2, 4
  • Keep the patient fasted until hemodynamically stable 3, 1
  • Endoscopy should only be performed after adequate resuscitation is achieved—ideally when blood pressure and central venous pressure are stable 3
  • Ensure endoscopy is performed by experienced endoscopists capable of therapeutic interventions (injection, thermal, or mechanical hemostasis) 3

Critical pitfall to avoid: Do not delay resuscitation to perform endoscopy, but also do not delay endoscopy once the patient is adequately resuscitated 3, 2

Special Considerations

Identify Liver Disease Early

  • Patients with significant liver disease require specific management protocols including vasoactive drugs and antibiotics 3, 2
  • Look for stigmata of chronic liver disease on physical examination 3

Upper vs Lower Source

  • Coffee ground emesis indicates an upper GI source, but up to 10-15% of patients with severe hematochezia may have an upper GI source 3, 2
  • The coffee ground appearance results from gastric acid converting hemoglobin to hematin 4

Post-Endoscopy Management

  • Continue close monitoring with continuous observation of pulse, blood pressure, and urine output 3, 1, 2
  • Patients who are hemodynamically stable 4-6 hours after endoscopy can begin drinking and eating a light diet 3, 1
  • Consider repeat endoscopy if there is clinical evidence of rebleeding: fresh hematemesis, fall in blood pressure, rise in pulse, or fall in CVP 3

Common Pitfalls to Avoid

  • Do not use single hematocrit measurements as the sole guide for bleeding severity—hemoglobin may not reflect acute blood loss initially 2
  • Do not over-transfuse—restrictive transfusion strategies improve outcomes 3
  • Do not perform endoscopy before adequate resuscitation—this increases risk of aspiration and poor visualization 3, 1
  • Do not forget to assess for liver disease—these patients need different management including vasoactive drugs and antibiotics 3

References

Guideline

Upper Gastrointestinal Bleeding Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hematemesis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Non-variceal Upper Gastrointestinal Bleeding and Its Endoscopic Management.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.